White Paper: 6 strategies for demonstrating the value of gene therapy to payers
Gene therapies offer dramatic new hope to patients with a range of unmet medical needs—but at what price? From the payer perspective, not all benefits justify reimbursement. And that can spell trouble for manufacturers.
This eye-opening paper from Precision experts Jeremy Schafer, PhD, and Alexander Grosvenor, PhD, will help you:
- Understand the disparities between payer and manufacturer expectations for long-term outcomes
- Determine which elements of treatment are included in the product cost
- Shift the dialogue from short-term results to long-term savings
- Gain 6 strategies to craft a compelling value story for a gene therapy
Don’t wait to develop your engagement strategy. Download the paper today.